Document Type : Case Report/Series
Authors
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences , Tehran, Iran
Abstract
Keywords
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
1.Zhong N. Neuronal ceroid lipofuscinoses and possible pathogenic mechanism. Mol Genet Metab. 2000;71(1-2):195- 206. [PubMed: 11001811]. https://doi.org/10.1006/mgme.2000.3057 PMid:11001811 |
||||
2. Peltonen L, Savukoski M, Vesa J. Genetics of the neuronal Karimi S et al. 54 Razavi Int J Med. 2018 | ||||
6(3): e60142. ceroid lipofuscinoses. Curr Opin Genet Dev. 2000;10(3):299- 305. [PubMed: 10826995]. https://doi.org/10.1016/S0959-437X(00)00086-1 PMid:10826995 |
||||
3. Wisniewski KE, Kida E, Patxot OF, Connell F. Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations. Am J Med Genet. 1992;42(4):525-32. [PubMed: 1319116]. https://doi.org/10.1002/ajmg.1320420420 PMid:1319116 |
||||
4. Sinha S, Satishchandra P, Santosh V, Gayatri N, Shankar SK. Neuronal ceroid lipofuscinosis: a clinicopathological study. Seizure. 2004;13(4):235-40. [PubMed: 15121131]. https://doi.org/10.1016/S1059-1311(03)00163-8 PMid:15121131 |
||||
5. Resource NC. A gateway for batten disease. London: University College London; 2009. | ||||
6. Worgall S, Kekatpure MV, Heier L, Ballon D, Dyke JP, Shungu D, et al. Neurological deterioration in late infantile neuronal ceroid lipofuscinosis. Neurology. 2007;69(6):521-35 [PubMed: 17679671]. https://doi.org/10.1212/01.wnl.0000267885.47092.40 PMid:17679671 |
||||
7. Santavuori P, Heiskala H, Westermarck T, Sainio K, Moren R. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease. Am J Med Genet Suppl. 1988;5:265- 74. [PubMed: 3146324]. https://doi.org/10.1002/ajmg.1320310629 PMid:3146324 |
||||
8. Weleber RG. The dystrophic retina in multi-system disorders: the electroretinogram in neuronal ceroid lipofuscinoses. Eye. 1998;12(3b):580-90. https://doi.org/10.1038/eye.1998.148 PMid:9775220 |
||||
9. Pampiglione G, Harden A. So-called neuronal ceroid lipofuscinosis. Neurophysiological studies in 60 children. J Neurol Neurosurg Psychiatry. 1977;40(4):323-30. [PubMed: 874509]. https://doi.org/10.1136/jnnp.40.4.323 PMid:874509 PMCid:PMC492698 |
||||
10. Dyken PR. Neuronal ceroid-lipofuscinoses. In: Swaiman KF, editor. Pediatric neurology principles and practice. 3rd ed. Philadelphia: Mosby Elsevier; 1999. P. 839-46. | ||||
11. Goebel HH. Morphologic diagnosis in neuronal ceroid lipofuscinosis. Neuropediatrics. 1997;28(1):67-9. [PubMed: 9151327]. https://doi.org/10.1055/s-2007-973672 PMid:9151327 |
||||
12. Dhar S, Bitting RL, Rylova SN, Jansen PJ, Lockhart E, Koeberl DD, et al. Flupirtine blocks apoptosis in batten patient lymphoblasts and in human postmitotic CLN3- and CLN2- deficient neurons. Ann Neurol. 2002;51:448-66. [PubMed: 11921051]. https://doi.org/10.1002/ana.10143 PMid:11921051 |
||||
13. Setty G, Saleem R, Khan A, Hussain N. Atypical juvenile neuronal ceroid lipofuscinosis: a report of three cases. J Pediatr Neurosci. 2013;8(2):117-9. [PubMed: 24082928]. https://doi.org/10.4103/1817-1745.117840 PMid:24082928 PMCid:PMC3783717 |
||||
14. Kohlschuetter A, Schulz A. CLN2 disease (classic late infantile neuronal ceroid lipofuscinosis). Pediatr Endocrinol Rev. 2016;13:682-8. [PubMed: 27491216]. |